Cargando…
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
[Image: see text] With increasing drug resistance in tuberculosis (TB) patient populations, there is an urgent need for new drugs. Ideally, new agents should work through novel targets so that they are unencumbered by preexisting clinical resistance to current treatments. Benzofuran 1 was identified...
Ejemplares similares
-
Identification
and Optimization of Novel Inhibitors
of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular
Activity
por: Green, Simon R., et al.
Publicado: (2023) -
Spirocycle MmpL3 Inhibitors with Improved hERG and
Cytotoxicity Profiles as Inhibitors of Mycobacterium
tuberculosis Growth
por: Ray, Peter C., et al.
Publicado: (2021) -
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
por: Wilson, Regina, et al.
Publicado: (2013) -
Mycobacterium tuberculosis Malate Synthase Structures with Fragments Reveal a Portal for Substrate/Product Exchange
por: Huang, Hsiao-Ling, et al.
Publicado: (2016) -
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
por: Aggarwal, Anup, et al.
Publicado: (2017)